esc guidelines 2010 on the management of atrial fibrillation

73
www.escardio.org/guidelines European Heart Journal 2010 European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) ESC Guidelines 2010 on the management of Atrial Fibrillation European Heart Journal (2010) 31, 2369-2429

Upload: leigh-fischer

Post on 31-Dec-2015

55 views

Category:

Documents


0 download

DESCRIPTION

ESC Guidelines 2010 on the management of Atrial Fibrillation. European Heart Journal 2010. European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal (2010) 31, 2369-2429. Classes of recommendations. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines

European Heart Journal 2010

European Heart Rhythm Association (EHRA);Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)

ESC Guidelines 2010 on the management of

Atrial Fibrillation

European Heart Journal (2010) 31, 2369-2429

Page 2: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Page 3: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Classes of recommendations

Page 4: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Levels of evidence

Page 5: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Clinical Events (outcomes) affected by AF

Page 6: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Conditions predisposing to, or encouraging progression of

AF

Page 7: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Types of Atrial Fibrillation

Page 8: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Clinical evaluation

Page 9: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Structural abnormalities associated with AF

Page 10: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

EHRA score of AF- related symptoms

AF = atrial fibrillation; EHRA = European Heart Rhythm Association

Page 11: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Natural time course of AF

AF = atrial fibrillation

Page 12: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Diagnosis and initial management of AF

aClass of recommendation.bLevel of evidence.AF = atrial fibrillation; ECG = electrocardiogram; EHRA = European Heart Rhythm Association.

Page 13: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Diagnosis and initial management of AF

aClass of recommendation.bLevel of evidence.AF = atrial fibrillation; ECG = electrocardiogram.

Page 14: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Diagnosis and initial management of AF

aClass of recommendation.bLevel of evidence.AF = atrial fibrillation; ECG = electrocardiogram.

Page 15: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

The management cascade for patients with AF

ACEI = angiotensin-converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin receptor blocker;PUFA = polyunsaturated fatty acid; TE = thrombo-embolism.

Page 16: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

CHADS2 score and stroke rate

*The adjusted stroke rate was derived from the multivariable analysis assuming no aspirin usage; these stroke rates arebased on data from a cohort of hospitalised AF patients, published in 2001, with low numbers in those with a CHADS2 scoreof 5 and 6 to allow an accurate judgement of the risk in these patients. Given that stroke rates are declining overall, actualstroke rates in contemporary non-hospitalised cohorts may also vary from these estimates. Adapted from Gage BF et al.

AF = atrial fibrillation; CHADS2 = cardiac failure, hypertension, age, diabetes, stroke (doubled).

Page 17: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Risk factors for stroke andthrombo-embolism in non-valvular

AF

AF= atrial fibrillation; EF = ejection fraction (as documented by echocardiography, radionuclide ventriculography, cardiaccatheterization, cardiac magnetic resonance imaging, etc.); LV = left ventricular; TIA = transient ischaemic attack.

Page 18: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Risk factor-based point-based scoring

system - CHA2DS2-VASc

*Prior myocardial infarction, peripheral artery disease, aortic plaque. Actual rates of stroke in contemporarycohorts may vary from these estimates.

Page 19: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Adjusted stroke rate according

to CHA2DS2-VASc score

Page 20: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Use of oral anticoagulation for

stroke prevention in AF

AF = atrial fibrillation; OAC = oral anticoagulant; TIA = transient ischaemic attack.

Page 21: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Approach to thromboprophylaxis in AF

AF = atrial fibrillation; CHA2DS2-VASc = cardiac failure, hypertension, age ≥ 75 (doubled), diabetes, stroke (doubled)-vascular disease, age 65–74 and sex category (female); INR = international normalized ratio; OAC = oral anticoagulation, such as a vitamin K antagonist (VKA) adjusted to an intensity range of INR 2.0–3.0 (target 2.5).

Page 22: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

The HAS-BLED bleeding risk score

*Hypertension is defined as systolic blood pressure > 160 mmHg.

INR = international normalized ratio.

Page 23: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Cardioversion, TOE and anticoagulation

AF = atrial fibrillation; DCC = direct current cardioversion; LA = left atrium; LAA = left atrial appendage; OAC = oral anticoagulant;SR= sinus rhythm; TOE= transoesophageal echocardiography.AF = atrial fibrillation; DCC = direct current cardioversion; LA = left atrium; LAA = left atrial appendage; OAC = oral anticoagulant;SR= sinus rhythm; TOE= transoesophageal echocardiography.

Page 24: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Prevention of thromboembolism in AF

Page 25: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Prevention of thromboembolism in AF

Page 26: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

aClass of recommendation. bLevel of evidence. AF = atrial fibrillation; CHADS2 = cardiac failure, hypertension, age, diabetes, stroke (doubled);INR = international normalized ratio; LMWH = low molecular weight heparin; OAC = oral anticoagulant; TIA = transient ischaemic attack; VKA = vitamin K antagonist.

Prevention of thromboembolism in AF

Page 27: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Drugs and doses for pharmacological

conversion of (recent-onset) AF

ACS = acute coronary syndrome; AF = atrial fibrillation; DCC = direct current cardioversion; i.v. = intravenous;N/A = not applicable; NYHA, New York Heart Association; p.o. = per os; QRS = QRS duration; QT = QT interval;T-U = abnormal repolarization (T-U) waves.

Page 28: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

DCC and pharmacological conversion

recent-onset AF

AF = atrial fibrillation; i.v. = intravenous.

Page 29: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Pharmacological cardioversion of AF

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; LoE = level of evidence; i.v. = intravenous.

Page 30: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

DC cardioversion for AF

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; DCC = direct current cardioversion.

Page 31: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

General Management of the AF Patient

Page 32: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of rate and rhythm control strategies

Page 33: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Rate and rhythm control of AF

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; EHRA = European Heart Rhythm Association.

Page 34: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Optimal level of heart rate control

Page 35: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Rate control of atrial fibrillation

The choice of drugs depends on life style and underlying disease

Page 36: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Drugs for rate control

ER = extended release formulations; N/A = not applicable. ‡Only in patients with non-permanent atrial fibrillation.

Page 37: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Acute rate control in AF

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; i.v. = intravenous.

Page 38: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Long-term rate control in AF

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; bmp = beats per minute; LV = left ventricular; NYHA = New York Heart Association.

Page 39: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Long-term rate control in AF

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; bmp = beats per minute; LV = left ventricular; NYHA = New York Heart Association.

Page 40: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

AV node ablation in AF patients

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; AV = atrioventricular; CRT = cardiac resynchronization therapy; LV = left ventricular;LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.

Page 41: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

AV node ablation in AF patients

aClass of recommendation. bLevel of evidence. AF = atrial fibrillation; AV = atrioventricular; CRT = cardiac resynchronizationtherapy; LV = left ventricular; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.

Page 42: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of pacemakers after

AV node ablation

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; AV = atrioventricular; CRT = cardiac resynchronization therapy; LV = left ventricular;LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.

Page 43: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Principles of antiarrhythmic drugtherapy to maintain sinus

rhythm1. Treatment is motivated by attempts to reduce AF-related

symptoms.

2. Efficacy of antiarrhythmic drugs to maintain sinus rhythm is modest.

3. Clinically successful antiarrhythmic drug therapy may reduce ratherthan eliminate recurrence of AF.

4. If one antiarrhythmic drug ‘fails’ a clinically acceptable responsemay be achieved with another agent.

5. Drug-induced proarrhythmia or extra-cardiac side-effects arefrequent.

6. Safety rather than efficacy considerations should primarily guidethe choice of antiarrhythmic agent.

Page 44: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Suggested doses and main caveats for

commonly used antiarrhythmic drugs

AF = atrial fibrillation; AV = atrioventricular; bpm = beats per minute; CYP = cytochrome P; ECG = electrocardiogram;LV = left ventricular; NYHA = New York Heart Association.

Page 45: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Suggested doses and main caveats for commonly used antiarrhythmic drugs

(Contd)

AF = atrial fibrillation; AV = atrioventricular; bpm = beats per minute; CYP = cytochrome P; ECG = electrocardiogram;LV = left ventricular; NYHA = New York Heart Association.

Page 46: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Suggested doses and main caveats for commonly used antiarrhythmic drugs

(Contd)

AF = atrial fibrillation; AV = atrioventricular; bpm = beats per minute; CYP = cytochrome P; ECG = electrocardiogram;LV = left ventricular; NYHA = New York Heart Association.

Page 47: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of antiarrhythmic for the patientwith no or minimal structural heart

disease

Page 48: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of antiarrhythmic drugaccording to underlying

pathology

ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; CAD = coronary artery disease; CHF = congestive heart failure;HT = hypertension; LVH = left ventricular hypertrophy; NYHA = New York Heart Association; unstable = cardiac decompensation within the prior4 weeks. Antiarrhythmic agents are listed in alphabetical order within each treatment box. ? = evidence for ‘upstream’ therapy for prevention of atrialremodelling still remains controversial.

Page 49: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of an antiarrhythmic drug

for AF control

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; AV = atrioventricular; LoE = level of evidence; NYHA = New York Heart Association.

Page 50: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of an antiarrhythmic drug

for AF control

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; AV = atrioventricular; LoE = level of evidence; NYHA = New York Heart Association.

Page 51: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice of an antiarrhythmic drug

for AF control

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; AV = atrioventricular; LoE = level of evidence; NYHA = New York Heart Association.

Page 52: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Choice between ablation and antiarrhythmic drug therapyfor patients with and without structural heart disease

†More extensive LA ablation may be needed; *usually PVI is appropriate. AF = atrial fibrillation; CAD = coronary artery disease; CHF = congestive heart failure; HT = hypertension; LVH = left ventricular hypertrophy;NYHA = New York Heart Association; PVI = pulmonary vein isolation. Antiarrhythmic agents are listed in alphabetical order within each treatment box.

Page 53: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Left atrial catheter ablation

aClass of recommendation. bLevel of evidence. AF = atrial fibrillation; i.v. = intravenous; LMWH = low molecular weightheparin; OAC = oral anticoagulant; UFH = unfractionated heparin.

Page 54: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Left atrial catheter ablation

aClass of recommendation.bLevel of evidence.AF = atrial fibrillation; i.v. = intravenous; LMWH = low molecular weight heparin; OAC = oral anticoagulant;UFH = unfractionated heparin.

Page 55: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Surgical ablation of AF

aClass of recommendation.bLevel of evidence.

AF = atrial fibrillation.

Page 56: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Primary prevention of AF

with “upstream” therapy

aClass of recommendation.bLevel of evidence.

ACEI = angiotensin-converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin receptor blocker.

Page 57: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Secondary prevention of AF

with “upstream” therapy

aClass of recommendation.bLevel of evidence.

ACEI = angiotensin-converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin receptor blocker.

Page 58: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Rate control during AF with heart failure

aClass of recommendation.bLevel of evidence.

AF = atrial fibrillation; AP = accessory pathway; LVEF = left ventricular ejection fraction.

Page 59: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Rate control during AF with heart failure

aClass of recommendation.bLevel of evidence.

AF = atrial fibrillation; AV = atrioventricular; CRT = cardiac resynchronization therapy;LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.

Page 60: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Rhythm control of AF in heart failure

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; DCC = direct current cardioversion; NYHA = New York Heart Association.

Page 61: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation in athletes

aClass of recommendation. bLevel of evidence. AF = atrial fibrillation.

Page 62: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation in valvular heart disease

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; INR = international normalized ratio; LA = left atrial; LV = left ventricular.

Page 63: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation inacute coronary

syndromes

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation, ACS = acute coronary syndrome; DCC = direct current cardioversion.

Page 64: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation in :

aClass of recommendation.bLevel of evidence.

AF = atrial fibrillation, ECG = electrocardiogram.

Page 65: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation in pregnancy

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; DCC = direct current cardioversion; LMWH = low molecular weight heparin;UFH = unfractionated heparin; VKA = vitamin K antagonist.

Page 66: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation in pregnancy

aClass of recommendation.bLevel of evidence.

AF = atrial fibrillation; DCC = direct current cardioversion.

Page 67: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Post-operative Atrial Fibrillation

aClass of recommendation.bLevel of evidence.

AF = atrial fibrillation; DCC = direct current cardioversion.

Page 68: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Post-operative Atrial Fibrillation

aClass of recommendation. bLevel of evidence.

AF = atrial fibrillation; DCC = direct current cardioversion.

Page 69: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fibrillation in hyperthyroidism

aClass of recommendation. bLevel of evidence. AF = atrial fibrillation.

Page 70: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

AF in Wolff-Parkinson-White syndrome

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; AP = accessory pathway; ECG = electrocardiogram; SCD = sudden cardiac death..

Page 71: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

AF in hypertrophic cardiomyopathy

aClass of recommendation. bLevel of evidence. AF = atrial fibrillation; DCC = direct current cardioversion;HCM = hypertrophic cardiomyopathy; INR = international normalized ratio.

Page 72: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines European Heart Journal (2010) 31, 2369-2429

Atrial Fribillation in pulmonary disease

aClass of recommendation. bLevel of evidence.AF = atrial fibrillation; DCC = direct current cardioversion.

Page 73: ESC Guidelines 2010  on the management of Atrial Fibrillation

www.escardio.org/guidelines

European Heart Rhythm Association (EHRA);Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)

European Heart Journal (2010) 31, 2369-2429